Allogeneic Hematopoietic Cell Transplantation (HCT) vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG and CIBMTR Study
   Google Scholar   
Citation:
Blood vol 132 (suppl 1) 2170
Meeting Instance:
ASH 2018
Year:
2018
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
3046  
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
Leukemia    Transplant    
Pharmas:
 
Grants:
UG1CA189823  
Corr. Author:
 
Authors:
                                                         
Networks:
CA043, CA087, IL043, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-NC010, LAPS-OH007, MN022, NY018   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
Alliance-A151509, CALGB-100103
Phases:
2, N/A
Keywords: